This application for an R15 Area Research Enhancement Award (AREA) is designed to examine the effectiveness of state Medicaid tobacco cessation policies. Tobacco use is the leading preventable cause of death and of cancer in the United States. Recent research demonstrates that a robust state program can lead to lower smoking rates, reduced cardiovascular hospitalizations and save $3 in hospital costs for every $1 invested. The three specific aims are: (1) to develop and analyze new data about the utilization of Medicaid tobacco cessation treatments at state levels from 2003 to 2011, based on Medicaid drug rebate files, and to link these to other state tobacco control and Medicaid policies, (2) to assess factors related to higher Medicaid treatment utilization using mixed mode research, including pooled time series panel analysis across the nation and case studies of six states, and (3) to examine the relationship between changes in states'Medicaid treatment utilization and other state policies with individual-level behaviors, including overall smoking prevalence and quit rates, using the 2003, 2006-7 and 2010-11 Tobacco Use Supplements of the Current Population Survey. The findings will provide better insights into Medicaid tobacco cessation efforts and the factors that lead to more effective policies. In keeping with the goals of AREA grants, students will be integral to the research process;the co-investigator is a mid-career PhD student and another graduate student will be supported. Analyses from this project will also be incorporated into the statistics course work, exposing a much larger number of students to the research. Our school has had relatively few NIH grants and receipt of this grant will help build our ability to conduct and compete for NIH- funded academic research.

Public Health Relevance

Low-income Medicaid beneficiaries are much more likely to smoke than the general population and the number of adult Medicaid beneficiaries is expected to surge. Understanding factors that lead to more effective tobacco cessation policies in Medicaid can contribute to the development of stronger state policies. These could improve health by reducing tobacco use in a high risk population and help contain health care costs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15CA176600-01A1
Application #
8626119
Study Section
Special Emphasis Panel (ZRG1-HDM-X (90))
Program Officer
Hartman, Anne
Project Start
2014-02-07
Project End
2017-01-31
Budget Start
2014-02-07
Budget End
2017-01-31
Support Year
1
Fiscal Year
2014
Total Cost
$475,181
Indirect Cost
$175,382
Name
George Washington University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
043990498
City
Washington
State
DC
Country
United States
Zip Code
20052
Ku, Leighton; Steinmetz, Erika; Bysshe, Tyler et al. (2017) Crossing Boundaries. Public Health Rep 132:164-170
Ku, Leighton; Brantley, Erin; Bysshe, Tyler et al. (2016) How Medicaid and Other Public Policies Affect Use of Tobacco Cessation Therapy, United States, 2010-2014. Prev Chronic Dis 13:E150
Ku, Leighton; Bruen, Brian K; Steinmetz, Erika et al. (2016) Medicaid Tobacco Cessation: Big Gaps Remain In Efforts To Get Smokers To Quit. Health Aff (Millwood) 35:62-70